Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Erbium 169Er

Erbium (169Er) citrate 111 MBq/ml suspension for injection (ERMM-1)

Active ingredient

Er169-citrate

Disease area

Rheumatology

Available in
, 

Erbium 169Er in Czech Republic

Product information
, 

Erbium 169Er in France

Product information
, 

Erbium 169Er in Germany

Product information
, 

Erbium 169Er in International

Product information
, 

Erbium 169Er in South America

Product information

Erbium 169Er in Spain

Product information

Rhenium 186Re

Rhenium (186Re) sulphide CIS bio international 148-370 MBq/mL suspension for intra-articular injection (Re-186-MM-1)

Active ingredient

Rhenium (186Re) sulphide colloid

Disease area

Rheumatology

Available in
, 

Rhenium 186Re in Czech Republic

Product information
, 

Rhenium 186Re in France

Product information
, 

Rhenium 186Re in Germany

Product information
, 

Rhenium 186Re in International

Product information
, 

Rhenium 186Re in South America

Product information

Rhenium 186Re in Spain

Product information

Yttrium 90Y

Yttrium (90Y) citrate CIS bio international 150-370 MBq/mL suspension for intraarticular injection (YMM-1)

Active ingredient

Y90-citrate

Disease area

Rheumatology

Available in
, 

Yttrium 90Y in Belgium

Product information
, 

Yttrium 90Y in Czech Republic

Product information
, 

Yttrium 90Y in France

Product information
, 

Yttrium 90Y in Germany

Product information
, 

Yttrium 90Y in Hungary

Product information
, 

Yttrium 90Y in International

Product information
, 

Yttrium 90Y in Italy

Product information
, 

Yttrium 90Y in Luxembourg

Product information
, 

Yttrium 90Y in Netherlands

Product information
, 

Yttrium 90Y in Slovakia

Product information
, 

Yttrium 90Y in South America

Product information
, 

Yttrium 90Y in Spain

Product information

Yttrium 90Y in Switzerland

Product information